Lanean...
Immunotherapy in inoperable stage III non-small cell lung cancer: a review
The leading cause of cancer-related deaths in the United States continues to be lung cancer. Approximately 25–30% of patients are diagnosed with locally advanced non-small cell lung cancer (NSCLC). Concurrent chemoradiation with a platinum-based doublet is the current standard of care for patients w...
Gorde:
| Argitaratua izan da: | Drugs Context |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
BioExcel Publishing Ltd
2019
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6586171/ https://ncbi.nlm.nih.gov/pubmed/31258616 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7573/dic.212578 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|